Key Market Segments
By Application
-
Drug optimization and repurposing
-
Preclinical testing
-
Others
By Therapeutic Area
-
Oncology
-
Neurodegenerative Diseases
-
Cardiovascular Disease
-
Metabolic Diseases
-
Infectious Disease
-
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
-
US
-
Canada
-
Mexico
Europe
-
Eastern Europe
-
Poland
-
Romania
-
Hungary
-
Turkey
-
Rest of Eastern Europe
-
-
Western Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Netherlands
-
Switzerland
-
Austria
-
Rest of Western Europe
-
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Vietnam
-
Singapore
-
Australia
-
Rest of Asia Pacific
Middle East & Africa
Middle East
-
UAE
-
Egypt
-
Saudi Arabia
-
Qatar
-
Rest of the Middle East
Africa
-
Nigeria
-
South Africa
-
Rest of Africa
Latin America
-
Brazil
-
Argentina
-
Colombia
-
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization to meet the company’s specific needs. The following customization options are available for the report:
-
Product Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Product Matrix which gives a detailed comparison of the product portfolio of each company
-
Geographic Analysis
-
Additional countries in any of the regions
-
Company Information
-
Detailed analysis and profiling of additional market players (Up to five)
Frequently Asked Questions
Ans: North America led the Artificial Intelligence in Drug Discovery Market in 2024, supported by strong pharmaceutical infrastructure, advanced AI adoption, and significant biotech collaborations.
Ans: Drug Optimization & Repurposing dominated the Artificial Intelligence in Drug Discovery Market, while Preclinical Testing is projected to record the fastest growth during the forecast period.
Ans: Key drivers include rising R&D costs, AI-powered molecular prediction, precision medicine demand, and big data integration to accelerate drug discovery and reduce costs.
Ans: In 2024, the Artificial Intelligence in Drug Discovery Market was valued at USD 1.92 billion, driven by AI applications in drug design, molecular modeling, and clinical simulation.
Ans: The Artificial Intelligence in Drug Discovery Market is expected to grow at a CAGR of 29.89% from 2025 to 2032, reflecting exponential adoption worldwide.